APA (7th ed.) Citation

Wicklein, D., Leal, N. R., Salamon, J., Thamer, M., Herrmann, H., Valent, P., . . . Ullrich, S. (2012). Nilotinib and imatinib are comparably effective in reducing growth of human eosinophil leukemia cells in a newly established xenograft model. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Wicklein, Daniel, Nuno Ramos Leal, Johannes Salamon, Mohammed Thamer, Harald Herrmann, Peter Valent, Udo Schumacher, and Sebastian Ullrich. Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model. Public Library of Science (PLoS), 2012.

MLA (8th ed.) Citation

Wicklein, Daniel, et al. Nilotinib and Imatinib Are Comparably Effective in Reducing Growth of Human Eosinophil Leukemia Cells in a Newly Established Xenograft Model. Public Library of Science (PLoS), 2012.